| Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005) |
|---|
| 08/22/2002 | WO2002064139A1 Treatment of parkinson's disease by the combined action of a compound with neurotrophic activity and a compound enhancing the dopamine activity |
| 08/22/2002 | WO2002064136A2 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 08/22/2002 | WO2002044159A3 1-(2-m-methanesulfonamidophenylethyl)-4-(m-trifluoromethylphenyl)piperazine and pharmaceutically acceptable salts and solvates thereof and their use in the treatment of incontinence |
| 08/22/2002 | WO2002032869A3 Substituted heterocyclic compounds for treating multidrug resistance |
| 08/22/2002 | WO2002013875A3 Complexes containing perfluoroalkyl with polar radicals, method for the production and use thereof |
| 08/22/2002 | US20020115863 Hydroxamate derivatives that inhibit peptidyl deformylase (PDF), antimicrobials and antibiotics |
| 08/22/2002 | US20020115852 7-(((5-Amino-1,2,4-thiadiazol-3-yl)-(Z)-(fluormethoxyimino) -acetyl)amino)-3(E)-((imino-1-piperazinylmethyl)-methylhydrazono)methyl-3 -cephem-4-carboxylic acid hydrochloride, for example |
| 08/22/2002 | US20020115826 Enzyme inhibitor for use for use in the treatment of cell proliferative defects |
| 08/22/2002 | US20020115806 Olefin polymerization catalyst system is a reaction product of a metallocenes and a cocatalyst containing fluoroaryl substituted secondary amine or phsophine compound and an anion containing group 13 element which is noncoordinatig |
| 08/22/2002 | US20020115724 Methods and agents for inhibiting protein aging |
| 08/22/2002 | US20020115715 Amine and amide derivatives as ligands for the neuropeptide Y Y5 receptor useful in the treatment of obesity and other disorders |
| 08/22/2002 | US20020115685 Novel N-(arylsulphonyl) amino acid derivatives, process for their preparation and pharmaceutical compositions containing them |
| 08/22/2002 | US20020115671 Inhibitors of p38-a kinase |
| 08/22/2002 | US20020115660 Labled isotopes of phenyl 4-(1,4-diazepin-1-yl)-2-amino phenyl sulfone derivatives used in nuclear magnetic resonance imaging and positron emission tomography |
| 08/22/2002 | US20020115659 Compounds having heterocyclic groups containing two nitrogen atoms for treating multidrug resistance |
| 08/22/2002 | US20020115655 Calcium channel blockers |
| 08/22/2002 | US20020115118 Multi-functional reagent for erythrocytes |
| 08/22/2002 | US20020115018 A positive resist formulation consists of nitrile containing tert-amine compound, an organic solvent and a base resin having an acidic functional group which is protected with an acid labile group, a photoacid generator |
| 08/22/2002 | CA2426535A1 Heteroaryl alkyl piperazine derivatives as fatty acid oxidation inhibitors |
| 08/21/2002 | EP1233013A1 Novel phenylalanine derivatives |
| 08/21/2002 | EP1232150A1 Urea derivatives as anti-inflammatory agents |
| 08/21/2002 | EP1231939A2 Oncolytic combinations for the treatment of cancer |
| 08/21/2002 | EP0934256B1 Process for the production of cyanocinnamamides |
| 08/21/2002 | EP0802179B1 Substituted amidinonaphthyl ester derivatives |
| 08/20/2002 | US6437137 Naphthyl compounds, intermediates, processes, compositions, and methods |
| 08/20/2002 | US6436999 Diacyl-substituted guanidines, a process for their preparation, their use as medicine or diagnostic aid, and medicine containing them |
| 08/20/2002 | US6436942 Enantiomers of 1[(4-chloro-phenyl) phenylmethyl]-4-[(4-methylphenyl) sulfony]piperazine |
| 08/20/2002 | US6436925 Better able to cross membranes; inhibitors of cysteine proteases like calpain i and ii and cathepsin b and l, can thus be used to control diseases associated with an elevated activity of calpain enzymes or cathepsin enzymes |
| 08/20/2002 | US6436152 Substituted 2-aminoalky-1,4-diaminobenzene compounds and oxidation dye precursor compositions containing same |
| 08/15/2002 | WO2002062784A1 Piperidinee derivatives as neurokinin 1 antagonists |
| 08/15/2002 | WO2002062778A2 Anti-thrombotic compounds, production and use thereof as medicaments |
| 08/15/2002 | WO2002062777A2 Amino ceramide-like compounds and therapeutic methods of use |
| 08/15/2002 | WO2002062766A2 Melanocortin-4 receptor binding compounds and methods of use thereof |
| 08/15/2002 | WO2002062763A2 Inhibition of raf kinase using quinolyl isoquinolyl or pyridyl ureas |
| 08/15/2002 | WO2002062748A1 Carboxylic amides, the production and use thereof as medicaments |
| 08/15/2002 | WO2002062745A1 Use of bicyclic esters or amides for the treatment of diseases responsive to enhanced potassium channel activity |
| 08/15/2002 | WO2002062308A2 Primary intermediates for oxidative coloration of hair |
| 08/15/2002 | US20020111369 Follicle stimulating hormone; contraceptives |
| 08/15/2002 | US20020111367 Phenyl substituted pyridine and benzene derivatives |
| 08/15/2002 | US20020111359 Side effect reduction of narcotics |
| 08/15/2002 | US20020111340 Antiallergens |
| 08/15/2002 | US20020111265 Group-15 cationic compounds for olefin polymerization catalysts |
| 08/15/2002 | US20020110560 Lowering elevated post-prandial blood glucose levels in mammals by increasing incretin half-life comprising administering inhibitor of Dipeptidyl Peptidase (DP IV) or enzymes having DP-IV-like activity |
| 08/15/2002 | US20020108187 3-(2-(quaternary ammonium)ethylamino)phenol halides such as 1-(2-(3-hydroxy-4-methyl-phenylamino)-ethyl)-3-methyl 3H-imidazol-1-ium chloride; orange couplers |
| 08/15/2002 | CA2436837A1 Carboxylic acid amides, the preparation thereof and their use as pharmaceutical compositions |
| 08/15/2002 | CA2435492A1 Antithrombotic compounds, the preparation thereof and their use as pharmaceutical compositions |
| 08/15/2002 | CA2433378A1 Primary intermediates for oxidative coloration of hair |
| 08/14/2002 | EP1231209A1 Prodrugs of non-steroidal anti-inflammatory and carboxylic acid containing compound |
| 08/14/2002 | EP1230232A2 Substituted 4h-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 08/14/2002 | EP1230231A2 Process for preparing n-(4-hydroxyphenyl)-n'-(4'-aminophenyl)-piperazine |
| 08/14/2002 | EP1230210A1 Aminoalcohol derivatives useful for the treatment of gastrointestinal disorders |
| 08/14/2002 | EP0968130A4 N-alkyl ammonium acetonitrile activators in dense gas cleaning and method |
| 08/14/2002 | EP0951438A4 Granular n-alkyl ammonium acetonitrile compositions |
| 08/14/2002 | EP0950016A4 Liquid compositions containing n-alkyl ammonium acetonitrile salts |
| 08/14/2002 | EP0790974B1 Substituted 4-biarylbutyric or 5-biarylpentanoic acids and derivatives as matrix metalloprotease inhibitiors |
| 08/14/2002 | EP0760362B1 diaminomethylidene derivative |
| 08/14/2002 | EP0722439B1 Hiv protease inhibitors |
| 08/14/2002 | DE10105014A1 Neues Verfahren zur Herstellung von Monoamiden der DTPA New process for the preparation of monoamides of the DTPA |
| 08/14/2002 | CN1364157A N-(indolcarbonyl) piperazin derivatives |
| 08/14/2002 | CN1364155A N-Cyanomethyl amides as protease inhibitors |
| 08/14/2002 | CN1364153A Substituted phenoxyacetic acids |
| 08/13/2002 | US6433185 N-(arylsulphonyl) amino acid derivatives, process for their preparation and pharmaceutical compositions containing them |
| 08/13/2002 | US6433182 Nitrosated and nitrosylated α-adrenergic receptor antagonist compounds, compositions and their uses |
| 08/08/2002 | WO2002060859A2 Cyclic derivatives as modulators of chemokine receptor activity |
| 08/08/2002 | WO2002060858A1 Novel compound having maillard reaction inhibitory activity |
| 08/08/2002 | WO2002018327A3 Guanidinobenzamides as mc4-r agonists |
| 08/08/2002 | WO2002006189A3 Aniline derivatives |
| 08/08/2002 | WO2002002744A3 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof |
| 08/08/2002 | WO2002002518A3 Compounds to treat alzheimer's disease |
| 08/08/2002 | US20020107390 Thyromimetic organic compounds |
| 08/08/2002 | US20020107284 Inhibitors of the EGF-receptor tyrosine kinase and methods for their use |
| 08/08/2002 | US20020107266 Amides used particularly in the treatment, prevention or amelioration of one or more symptoms of malaria or Chagas' disease; inhibiting the activity of falcipain or cruzain |
| 08/08/2002 | US20020107255 Potent and selective inhibitors of chemokine binding to its receptor CCR1 found on inflammatory and immunomodulatory cells (preferably leukocytes and lymphocytes). |
| 08/08/2002 | US20020107241 N-heterocyclic derivatives useful for treating or preventing neuronal damage associated with neurological disease |
| 08/08/2002 | US20020107235 Carbamate and hydroxy groups containing phenanthrene derivatives; useful to treat obesity, diabetes and inflammation |
| 08/08/2002 | DE10104598A1 Carbonsäureamide, deren Herstellung und deren Verwendung als Arzneimittel Carboxamides, their preparation and their use as medicaments |
| 08/08/2002 | DE10104597A1 Antithrombotische Verbindungen, deren Herstellung und deren Verwendung als Arzneimittel Antithrombotic compounds, their preparation and their use as medicaments |
| 08/08/2002 | CA2432369A1 Cyclic derivatives as modulators of chemokine receptor activity |
| 08/07/2002 | EP1229029A1 Process for producing benzylamine compound |
| 08/07/2002 | EP1229010A1 Novel diarylamide derivatives and use thereof as medicines |
| 08/07/2002 | EP1228054A1 Compounds and their use as cysteine protease inhibitors |
| 08/07/2002 | EP1228053A1 Substituted piperazine derivatives, the production and use thereof as inhibitors of the microsomal triglyceride transfer protein (mtp) |
| 08/07/2002 | EP1228052A1 1-cyclic amino-alkylcyclohexane compounds, pharmaceutical compositions thereof, and their use as anticonvulsants |
| 08/07/2002 | EP1228024A1 Novel hydronaphtalene compounds, prepared by a rhodium catalyzed ring opening reaction in the presence of phosphine ligand |
| 08/07/2002 | EP1077976B1 Water soluble azoles as broad-spectrum antifungals |
| 08/07/2002 | EP1025107B1 Photochromic compounds |
| 08/07/2002 | EP0801649B1 Hydroxylamine derivatives useful for enhancing the molecular chaperon production and the preparation thereof |
| 08/07/2002 | CN1362954A Sulfamato hydroxamic acid metalloprotease inhibitor |
| 08/07/2002 | CN1362947A N-cyanomethylamides as protease inhibitors |
| 08/06/2002 | US6429328 Processes and intermediate compounds for preparing guanidine and amidine derivatives |
| 08/06/2002 | US6429317 Indane derivatives for antipsychotic compositions |
| 08/06/2002 | US6428780 Modified amino acid |
| 08/06/2002 | CA2208682C Fibrinogen receptor antagonists having substituted .beta.-amino acid residues and pharmaceutical compositions comprising the same |
| 08/01/2002 | WO2002059102A2 Urea derivatives, method for preparing same, use thereof as medicines, pharmaceutical compositions and use |
| 08/01/2002 | WO2002059101A1 Process for preparing higher primary alkanols |
| 08/01/2002 | WO2002059080A2 Trisubstituted carbocyclic cyclophilin binding compounds and their use |
| 08/01/2002 | WO2002059077A1 Aminoethanol derivatives |
| 08/01/2002 | WO2002059076A1 Method for producing dtpa monoamides |
| 08/01/2002 | WO2002059074A1 Benzylamine analogue |
| 08/01/2002 | WO2002058690A2 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors |